IQVIA Holdings Inc.

IQV · Healthcare

$259.88
+0.39% today

What a holder would want to know before buying IQV: where the price sits in its own history, how far it has fallen before and whether it recovered, and what the business behind it earns. All of it is arithmetic over free market data — no opinions, no recommendations.

Where the price sits
Low $156.66 · Apr 2026High $275.02 · Sep 2026

Today’s price is 66% above the lowest point of the past year and 6% below the highest.

Over the past year it was cheaper than today on 90% of days and more expensive on 10%. Over the last 10 years: cheaper on 97% of days.

26% above its average price of the last 200 trading days.

How bad does it get

Fell 20% or more once in 10 years. The deepest fall was 49%; the longest took 7 months to get back to its peak. Every one recovered.

Now 8% below the Dec 2021 peak.

Feb 2020
−49%back in 7 months
What you own

IQVIA Holdings Inc. · Healthcare · Diagnostics & Research · a large company worth $42.78B

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates…

Is it making money?
2022
2023
2024
2025

revenue profit

Sales of $16.31B in 2025, with $1.36B of profit. Sales grew in 3 of the last 3 years.

Keeps about 8 cents of every dollar of sales as profit.

Is it healthy?
Cash
$2.08B
Debt
$16.25B
Free cash flow / yr
$2.15B

Would need about 7.6 years of free cash flow to repay all its debt.

Is it expensive?

You pay $32 for every $1 of last year’s profit, and $18 for every $1 of profit expected next year.

A high number means buyers expect growth; a low one means they expect little, or fear trouble. Large US companies have averaged roughly 15–20 over the decades.

Pays no dividend.

What others are doing

22 analysts: 19 say buy, 3 hold, 0 sell. Their average 12-month target is $295.05 (range $250.00–$345.00).

Insiders made 0 purchases and 6 sales in the last 6 months. Executives routinely sell shares they were paid in; buying with their own money is the rarer signal.

Free data from Yahoo Finance, refreshed daily. This is evidence about the business and its price history, not a recommendation.

Now try it without risking anything

Poshkan is paper trading: real prices, virtual money. Buy IQV with $10,000 that isn’t real, set a stop before you enter, and find out what your idea would actually have done.

Data from Yahoo Finance, refreshed hourly. Nothing here is financial advice. Poshkan is a paper-trading simulator — all money, trades and returns are virtual.